MedPath

Valganciclovir

Generic Name
Valganciclovir
Brand Names
Valcyte
Drug Type
Small Molecule
Chemical Formula
C14H22N6O5
CAS Number
175865-60-8
Unique Ingredient Identifier
GCU97FKN3R

Overview

Valganciclovir hydrochloride (Valcyte, manufactured by Roche) is an antiviral medication used to treat cytomegalovirus infections. As the L-valyl ester of ganciclovir, it is actually a prodrug for ganciclovir. After oral administration, it is rapidly converted to ganciclovir by intestinal and hepatic esterases.

Background

Valganciclovir hydrochloride (Valcyte, manufactured by Roche) is an antiviral medication used to treat cytomegalovirus infections. As the L-valyl ester of ganciclovir, it is actually a prodrug for ganciclovir. After oral administration, it is rapidly converted to ganciclovir by intestinal and hepatic esterases.

Indication

Valganciclovir is an antiviral medication used for the treatment of cytomegalovirus infections.

Associated Conditions

  • Cytomegalovirus (CMV) Infections
  • Cytomegalovirus Retinitis

FDA Approved Products

Valganciclovir
Manufacturer:Camber Pharmaceuticals, Inc.
Route:ORAL
Strength:450 mg in 1 1
Approved: 2019/11/15
NDC:31722-832
Valganciclovir
Manufacturer:American Health Packaging
Route:ORAL
Strength:50 mg in 1 mL
Approved: 2023/08/22
NDC:60687-765
Valganciclovir
Manufacturer:American Health Packaging
Route:ORAL
Strength:450 mg in 1 1
Approved: 2022/10/14
NDC:68084-965
Valganciclovir
Manufacturer:Major Pharmaceuticals
Route:ORAL
Strength:450 mg in 1 1
Approved: 2018/09/17
NDC:0904-6796
Valcyte
Manufacturer:H2-Pharma, LLC
Route:ORAL
Strength:50 mg in 1 mL
Approved: 2023/04/14
NDC:61269-485

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath